Virta Health vs Omada Health

Side-by-side comparison of model-estimated upside.

Virta Health

-16%

est. 2Y upside i

HealthcareSeries D+

Rank

#2757

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Given a stale $2B valuation from 2021, high preference overhang, and likely near-term dilution, the expected 2-year return for common stock is -16.1%.

Last updated: July 19, 2026

Omada Health

+59%

est. 2Y upside i

HealthcareSeries D+

Rank

#745

Sector

Digital Health / Virtual Care

Est. Liquidity

~0Y

Data Quality

Data: High

Omada Health offers a compelling equity opportunity for a job candidate, with a public stock providing liquidity and a 2-year expected upside of ~59% net of dilution.

Last updated: July 19, 2026

Note: These companies have different risk levels. Virta Health (Higher Risk) and Omada Health (Moderate Risk). A higher expected upside in a higher-risk company comes with greater uncertainty. Compare within the same risk tier for more meaningful evaluation.

Upside Comparison

Expected Upside

Virta Health

-16%

Omada Health

+59%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.